Global Home Global Home  

Investor FAQs

What does Sonoma Pharmaceuticals do?

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company dedicated to identifying, developing and commercializing unique, differentiated therapies to millions of patients living with chronic skin conditions. Sonoma believes its products, which are sold throughout the United States and internationally, have improved patient outcomes for more than five million patients globally by treating and reducing certain topical skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain and harmful inflammatory responses. The company's headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America. European marketing and sales are headquartered in Roermond, Netherlands. More information can be found at

Who are Sonoma Pharmaceuticals customers?

It is currently a mix of dermatologists and wound care doctors/nurses.

When was Sonoma Pharmaceuticals founded?

The company was incorporated in California in 1999 as Micromed Laboratories, Inc. In August 2001, the company changed its name to Oculus Innovative Sciences, Inc. In December 2006, the company reincorporated in Delaware. Then in December 2016, the company changed its name to Sonoma Pharmaceuticals, Inc.

Where is Sonoma Pharmaceuticals located?

Our principal executive offices are located at:

1129 N. McDowell Blvd.

Petaluma, California 94954

Tel: (707) 283-0550

We have two subsidiaries: Oculus Technologies of Mexico, S.A. de C.V., organized in Mexico, and Sonoma Pharmaceuticals Netherlands, B.V., organized in the Netherlands.

How many employees does Sonoma have?

As of March 31, 2017, Sonoma employed a total of 75 employees in the United States and the Netherlands. Additionally, Sonoma had 138 employees in Mexico, all of which were contracted through an employment agency. As of March 31, 2017, Sonoma had a U.S. direct sales force of 30 employees, 2 district managers, and 3 senior managers. Sonoma is not a party to any collective bargaining agreements. Sonoma believes its relations with its employees are good.

When was Sonoma Pharmaceuticals' initial public offering, and what was the offering price?

Sonoma Pharmaceuticals, Inc. went public on January 25, 2007 under its former name, Oculus Innovative Sciences, Inc., and the offering price was $8.00 per share.

What is the company's CUSIP number?

Sonoma Pharmaceuticals’ CUSIP number is 83558L105 for common stock and 83558L113 for public warrants.

What is Sonoma Pharmaceuticals' stock symbol and on what stock exchange is it listed?

Sonoma’s stock symbol is SNOA (warrants: SNOAW) and both the common stock and the publicly traded warrants are listed on the Nasdaq Capital Market system.

When is Sonoma Pharmaceuticals' fiscal quarter and year-end dates?

Sonoma Pharmaceuticals operates on a fiscal year ending March 31st. Our quarterly reporting periods end on June 30th, September 30th, December 31st and March 31st.

Who is Sonoma Pharmaceuticals' transfer agent and how does a registered shareholder contact the agent regarding account information?

Sonoma Pharmaceuticals' transfer agent is:

By Regular Mail
P.O. Box 505000, Louisville, KY 40233

By Overnight Delivery
462 South 4th Street, Suite 1600, Louisville, KY 40202

Toll Free 888-647-8901
Toll +1 (201) 680-6578

If I own certificated shares of Sonoma Pharmaceuticals and have misplaced my stock certificate, what can I do?

You can contact Sonoma Pharmaceuticals' transfer agent, Computershare

I've recently moved. How do I submit my new address?

You must contact our transfer agent, Computershare

Who are the auditors of Sonoma Pharmaceuticals?

Marcum LLP, New York, New York

Who is the company's outside legal counsel?

Amy Trombly, Esq.
Trombly Business Law, PC
(617) 243-0060

Does Sonoma Pharmaceuticals currently offer a direct stock purchase plan?

The company does not offer a direct stock purchase program.

Does Sonoma Pharmaceuticals pay a cash dividend on its shares of common stock?

We have never paid our stockholders cash dividends, and we do not anticipate paying any cash dividends in the foreseeable future as we intend to retain any earnings for use in our business.

Who are the Sonoma's officers & directors?

Sonoma’s officers and directors can be found on the Corporate Governance page of the investor relations website.

How can I contact someone at Sonoma Pharmaceuticals with a question or request?

Please visit the Contact Us page on the Company website. Email addresses for specific questions and concerns are provided. Additionally, Sonoma Pharmaceuticals can be reached by calling (707) 283-0550.

How can I find information on Sonoma's filings?

Sonoma’s SEC filings can be obtained by visiting the SEC Filings page or by visiting

Who handles investor relations for Sonoma Pharmaceuticals?

Investor relations is handled by Sonoma Pharmaceuticals' internal staff. For additional information, please contact Bob Miller at (925) 787-6218 or